Skip to main navigation Skip to search Skip to main content

SAR of 4-alkoxybenzoic acid inhibitors of the trypanosome alternative oxidase.

  • Alejandro Meco Navas
  • , Godwin Ebiloma
  • , Ana Martín Domínguez
  • , Irene Martínez Benayas
  • , Eduardo J. Cueto-Díaz
  • , Amani Saud Alhejely
  • , Emmanuel Oluwadare Balogun
  • , Machi Saito
  • , Miho Matsui
  • , Natsumi Arai
  • , Tomoo Shiba
  • , Shigeharu Harada
  • , Harry P. De Koning
  • , Christophe Dardonville

Research output: Contribution to journalArticlepeer-review

Abstract

The SAR of 4-hydroxybenzaldehyde inhibitors of the trypanosome alternative oxidase (TAO), a critical enzyme for the respiration of bloodstream forms of trypanosomes, was investigated. Replacing the aldehyde group with a methyl ester resulted in a 10-fold increase in TAO inhibition and activity against T. brucei. Remarkably, two analogues containing the 2-hydroxy-6-methyl scaffold (9e and 16e) displayed single digit nanomolar TAO inhibition, which constitute the most potent 4-alkoxybenzoic acid derivatives described to date. 9e was 50-times more potent against TAO and 10-times more active against T. brucei compared to its benzaldehyde analogue 1. The farnesyl derivative 16e was as potent a TAO inhibitor as ascofuranone with IC50 = 3.1 nM. Similar to ascofuranone derivatives, the 2-hydroxy and 6-methyl groups seemed essential for low nanomolar TAO inhibition of acid derivatives, suggesting analogous binding interactions with the TAO active site.
Original languageEnglish
Article number923-928
JournalACS Medicinal Chemistry Letters
Volume9
Issue number9
DOIs
Publication statusPublished - 31 Jul 2018

Fingerprint

Dive into the research topics of 'SAR of 4-alkoxybenzoic acid inhibitors of the trypanosome alternative oxidase.'. Together they form a unique fingerprint.

Cite this